An Act to Direct the Comptroller General of the United States to Complete a Study on Barriers to Participation in Federally Funded Cancer Clinical Trials by Populations That Have Been Traditionally Underrepresented in Such Trials.
(eBook)

Book Cover
Average Rating
Published
[Washington, D.C.] : [U.S. Government Publishing Office], [2021].
Status

Description

Loading Description...

Also in this Series

Checking series information...

More Like This

Loading more titles like this title...

More Details

Format
eBook
Language
English

Notes

General Note
"Jan. 5, 2021 (H.R. 1966)."
General Note
"134 Stat. 4894."
General Note
"Public Law 116-291."
General Note
GPO Cataloging Record Distribution Program (CRDP).

Citations

APA Citation, 7th Edition (style guide)

United States. (2021). An Act to Direct the Comptroller General of the United States to Complete a Study on Barriers to Participation in Federally Funded Cancer Clinical Trials by Populations That Have Been Traditionally Underrepresented in Such Trials . [U.S. Government Publishing Office].

Chicago / Turabian - Author Date Citation, 17th Edition (style guide)

United States. 2021. An Act to Direct the Comptroller General of the United States to Complete a Study On Barriers to Participation in Federally Funded Cancer Clinical Trials By Populations That Have Been Traditionally Underrepresented in Such Trials. [U.S. Government Publishing Office].

Chicago / Turabian - Humanities (Notes and Bibliography) Citation, 17th Edition (style guide)

United States. An Act to Direct the Comptroller General of the United States to Complete a Study On Barriers to Participation in Federally Funded Cancer Clinical Trials By Populations That Have Been Traditionally Underrepresented in Such Trials [U.S. Government Publishing Office], 2021.

MLA Citation, 9th Edition (style guide)

United States. An Act to Direct the Comptroller General of the United States to Complete a Study On Barriers to Participation in Federally Funded Cancer Clinical Trials By Populations That Have Been Traditionally Underrepresented in Such Trials [U.S. Government Publishing Office], 2021.

Note! Citations contain only title, author, edition, publisher, and year published. Citations should be used as a guideline and should be double checked for accuracy. Citation formats are based on standards as of August 2021.

Staff View

Grouped Work ID
bc56512b-c2f2-7383-97e0-0208009b9aac-eng
Go To Grouped Work

Grouping Information

Grouped Work IDbc56512b-c2f2-7383-97e0-0208009b9aac-eng
Full titleact to direct the comptroller general of the united states to complete a study on barriers to participation in federally funded cancer clinical trials by populations that have been traditionally under
Authorunited states
Grouping Categorybook
Last Update2023-05-05 15:45:20PM
Last Indexed2024-04-21 00:46:58AM

Book Cover Information

Image Sourcedefault
First LoadedSep 12, 2022
Last UsedDec 28, 2023

Marc Record

First DetectedMar 30, 2021 12:00:00 AM
Last File Modification TimeMay 05, 2023 03:52:34 PM

MARC Record

LEADER02433cam a2200505 i 4500
001on1243899589
003OCoLC
00520210614144401.0
006m     o  d f      
007cr |||||||||||
008210330s2021    dcu     ol   f000 0 eng c
040 |a GPO|b eng|e rda|e pn|c GPO|d OCLCO|d OCLCF|d GPO|d MvI
042 |a pcc
043 |a n-us---
074 |a 0575-A-02 (online)
0860 |a AE 2.110:116-291
088 |a Public Law 116-291
099 |a AE 2.110:116-291
1101 |a United States,|e enacting jurisdiction.
24010|a Henrietta Lacks Enhancing Cancer Research Act of 2019
24513|a An Act to Direct the Comptroller General of the United States to Complete a Study on Barriers to Participation in Federally Funded Cancer Clinical Trials by Populations That Have Been Traditionally Underrepresented in Such Trials.
264 1|a [Washington, D.C.] :|b [U.S. Government Publishing Office],|c [2021]
300 |a 1 online resource (2 unnumbered pages)
336 |a text|b txt|2 rdacontent
337 |a computer|b c|2 rdamedia
338 |a online resource|b cr|2 rdacarrier
500 |a "Jan. 5, 2021 (H.R. 1966)."
500 |a "134 Stat. 4894."
500 |a "Public Law 116-291."
500 |a GPO Cataloging Record Distribution Program (CRDP).
588 |a Description based on online resource; title from PDF title page (govinfo website, viewed March 30, 2021).
650 0|a Cancer|x Research|z United States.
650 0|a HeLa cells.
650 0|a Minorities|x Health and hygiene|z United States.
650 7|a Cancer|x Research.|2 fast|0 (OCoLC)fst00845497
650 7|a HeLa cells.|2 fast|0 (OCoLC)fst00952578
650 7|a Minorities|x Health and hygiene.|2 fast|0 (OCoLC)fst01023167
651 7|a United States.|2 fast|0 (OCoLC)fst01204155
655 7|a Statutes and codes.|2 fast|0 (OCoLC)fst01774314
655 7|a Statutes and codes.|2 lcgft
77608|i Print version:|a United States.|s Henrietta Lacks Enhancing Cancer Research Act of 2019.|t Act to Direct the Comptroller General of the United States to Complete a Study on Barriers to Participation in Federally Funded Cancer Clinical Trials by Populations That Have Been Traditionally Underrepresented in Such Trials|w (OCoLC)1256450821
85640|3 PDF version|u https://purl.fdlp.gov/GPO/gpo153604
85640|3 Text version|u https://purl.fdlp.gov/GPO/gpo153605
922 |a BIBCONEW|b 20210330
949 |a AE 2.110:116-291|t x